Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary

March 31, 2022

New York Stock Exchange US Materials Chemicals earnings 37 min

Earnings Call Speaker Segments

Nick Bigney

executive
#1

Thanks, and good morning to all of you; we're glad you could join us today. With me on this call and taking part are John Gibson, our Chairman, Chief Executive Officer and President; Michael Borton, our Chief Financial Officer; Ryan Ezell, our Chief Operating Officer; and James Silas, Interim President of Data Analytics and Senior Vice President of Research and Innovation. During this call, we'll begin with prepared remarks about our business and the results for the quarter. After that, we'll take your questions; our earnings announcement for the 2021 fourth quarter and full year results has now been released — that's the fourth quarter and full year results — and it's posted on our website. We've also put an investor presentation up on our website. This call is being webcast, and a replay will be accessible on our website as well. Please keep in mind that anything we say today about projections or what we expect for future events counts as forward-looking statements. Such statements carry a number of risks and uncertainties, many of which we cannot control and which may cause actual results to differ materially from what we currently expect. We encourage listeners to look over our earnings release and the risk factors described in our filings with the SEC. Also, please see the reconciliations included in the earnings press release, since we might discuss non-GAAP metrics on this call. And with that, I'll hand things over to John.

John Gibson

executive
#2

Thanks, Nick, and good morning. I want to express my appreciation for your participation in this discussion about our results for the fourth quarter and the full year of 2021. For numerous companies and people, 2021 proved to be yet another tough twelve months. Disruptions in supply chains turned into a common phrase. Anxiety regarding inflation has affected the market. And while we are holding this call, hostilities involving Ukraine and Russia persist. Even though 2021 was a hard year at Flotek, we seized the chance to make our firm stronger, in terms of both finances and operations. We have also taken the time to become intensely focused on our strategic goals; those goals direct us toward concentrating on impeccable implementation, growth that is profitable, and reinforcing our financial standing; during this call, I will emphasize these strategic priorities by examining what we achieved in 2021, not all of which might be apparent from a strict look at the financial statements; these achievements are what set us on the course toward transformative transactions such as the ProFrac agreement that was announced recently. We think that Flotek in 2022 and afterward will look vastly different from the form it takes as it leaves 2021. So today, rather than concentrating on what is behind us, allow me to tell you about the Flotek of tomorrow. Our strategic priorities rest on a fundamental dedication to environmental leadership. Over the past several years, the phrase ESG has attracted an enormous amount of attention; yet, as with numerous subjects in mainstream conversation, popular things frequently enjoy their time in the spotlight before disappearing. At Flotek, we hold the view that ideas concerning better environmental stewardship cannot be separated from sustainable growth over the long term within the energy sector. Beyond the matter of preserving a social license to operate, businesses already face growing pressure regarding water availability, reducing waste, and getting the most out of operational efficiency when cost structures are tighter. Our offerings and services, which include our specialty green chemistry solutions, our Verax analyzers, and our Data Analytics, assist our clients in reducing their environmental footprint and in making prompt, effective operational choices. This rationale, environmental leadership, is a crucial component of our business strategy now and will remain so going forward. To fulfill our mission of being the preferred collaborative environmental partner for sustainable chemistry technology and Digital Analytics solutions, we will keep concentrating on impeccable implementation of our vision. Morris Chang once observed that strategy without execution has no direction, while execution without strategy accomplishes nothing. The possibilities before us today came from our vision. How well we carry things out will determine whether we become a leader in this space. Across the whole company, Flotek will continue putting safety and service quality first. Reaching zero total recordable incidents and zero nonproductive time for our customers in 2021 is something that makes me extremely proud of the Flotek team, and throughout 2022 we will keep strengthening that focus. In my entire career, I can honestly say this marks the first time I have ever achieved a zero TRIR along with no nonproductive time. That is a tremendous achievement, and my congratulations go out to the operations team and every one of our employees — truly remarkable. The steady focus we place on safety and the results we deliver there show that Flotek is an organization that actively handles risk, for our own sake and for our partners'. Throughout 2022 and afterward, Flotek will keep extending the headway achieved during 2021 and will rebuild ties with indirect routes to market via energy service companies, a vitally important part of the market; as a matter of fact, service companies accounted for half of our new energy chemistry customers during 2021. Hands down, the biggest win on our path to sustainable revenue is the new deal we signed with ProFrac — over $2 billion in revenue spread across the next ten years, kicking off on April 1. If you happened to miss our in-depth discussion about that ProFrac agreement, please go listen to the replay of our investor call from March 10, because as this momentum builds, we'll keep making our partnerships stronger by winning every single day, staying committed to building trust through dependability and the caliber of what we make and deliver, seamless logistics, openness, and value that benefits everyone involved. Heading into 2022, we arrive as a much leaner, more efficient company — and that came from bringing our entire organization into line with our vision. We've rebuilt how we approach business development, along with the tools that support it, to accelerate revenue growth and make forecasting work more smoothly together with our supply team. New strategies for managing the supply chain are now in place, ensuring we have several sourcing options — in basin sourcing among them — which has reduced what we spend on operations and logistics. Thanks to these changes, customers receive better service from us, and our margins have improved considerably. As of 2022 and going forward, Flotek is a lean organization that runs efficiently. Moving forward, we'll maintain our financial discipline by continuing with the cost-saving efforts we began in 2019, and we're managing our SG&A and our non-cost well, both of which have improved since 2020 by 11% and 23%, respectively. In the same way, we began 2022 with more openness regarding our margin reporting, and that will show up in our 10-K once it comes out. There's a saying that things get managed when they get measured. Mike Borton will go into further detail about a few of the adjustments you'll notice going forward. Finally, whether we succeed as an organization over the long run depends on having the proper leaders, teams, and structure in place to fuel profitable growth far into the future. Our cost structure has been altered, along with how we engage our markets, plus we've brought in new leadership to sharpen our reaction to uncertainty and bolster operational excellence as well as top line revenue growth exceeding 4x within just the coming 3 years; that is what prompted establishing a Chief Operating Officer position. Ryan Ezell became our COO during early March. There's zero doubt in my mind that Ryan alongside the Flotek team will achieve success going forward. Back in December, we additionally appointed Dr. James Silas, who right now holds the role of our Interim Head of Data Analytics. He continues to retain his prior post as Senior Vice President of Research and Innovation. For those of you listening who haven't gotten the chance to become acquainted with James Silas, I'd like to offer a bit of his history. Before joining Flotek 8 years ago, James spent 15 years working in academic research, studying the physics and chemistry of surfactants and polymers, personal care products, bioengineering, and our oil industry. Since coming to Flotek, James has played an essential part in our environmental leadership strategy, in creating the ESG green scorecard, and in shaping our intellectual property strategy. James has a lengthy association with JP3 and has had a substantial hand in developing our differentiated technologies. One major factor that sets Flotek's green chemistry offering apart from rivals is the guidance James provides. Beyond his technical qualifications, James brings an exceptional commercial mindset and stays deeply involved with our client base. Given all that, I named him Interim Head of Data Analytics, and in that capacity he has already delivered remarkable value—I anticipate even more contributions from him as we move further into the year. So now, I'll hand things over to James Silas, who will share his thoughts on the data analytics segment. James?

James Silas

executive
#3

Thanks for those generous remarks, John, and hello everybody. Although we fell short of our targets for the segment in Q4, I've been able to collaborate closely with the team since December. And what I've seen of our customer engagements and the market opportunities ahead of us has impressed me. Let me share a few observations regarding the Data Analytics segment. To begin, our core JP3 technology. Our new infrared analyzers strike a refined balance among measurement speed, application versatility and rugged operating conditions. Each minute, we're delivering data that fuels operational efficiencies. These vital compositional and visible property measurements let our customers handle their product and inventory more effectively by fine-tuning blending and separation processes in real time. Because our solutions have enterprise-wide impacts, our sales and marketing efforts need to shift so they align with our customers' leadership. Although our sales efforts so far have produced strong use cases, we're broadening our focus past siloed single-level applications toward enterprise-wide solutions and partnerships. We'll keep elevating our engagements with C-suite customers, particularly to communicate the value proposition, the technology we enable and meaningful gains in ESG performance. Access to essential real-time information underpins decisions that lower carbon footprint, energy consumption and emissions, that automate large-scale processes and that cut waste and inefficient reprocessing. Optical analyzers' versatility in edge embedded chemometric modeling means we possess the platform able to deliver next-generation reductions in greenhouse gas emissions. Last, during 2021 we launched multiple international pilot programs that are presently at differing stages of execution. These pilots remain on schedule, and we're confident they'll demonstrate the value proposition already proven in our North American markets and will give us a clear growth trajectory. To sum up, the technology needed to drive the next generation of ESG performance worldwide exists here and now. With that, I'll hand the call to Ryan to cover our Chemistry Technology segment.

Ryan Ezell

executive
#4

Thanks, James. I'll now cover how our Chemistry Technology segment performed, which covers both Energy Chemistry Technologies and the Professional Chemistries we provide for industrial and consumer chemistry needs. Once Q4 wrapped up, I'm happy to say our Energy Chemistry Technology approach — being the go-to collaborative partner for sustainable, optimized chemistry solutions — has been carried out completely and is building momentum. Flotek's distinctive offerings aim to boost what customers get by improving their ESG results, cutting operating expenses, and generating a better return on invested capital. We keep seeing expansion among domestic and international E&P operators, plus service companies, which fulfills our ongoing pledge to broaden our revenue base and reduce the danger of relying too heavily on a few customers. During Q4, we saw our sped-up structural adjustments already producing benefits, since our costs kept falling while our top-line growth beat that of the domestic hydraulic fracturing fleet market. On top of that, we closed out the year with outstanding results in safety, service quality, and customer satisfaction. So I'm happy to share these Q4 highlights. To start, Energy Chemistry Technologies revenue climbed 32% versus the previous quarter, clearly beating the market and pointing to ongoing market share gains. That represents a 26% gain over Q4 a year earlier. Next, revenue from domestic accounts rose 34%, whereas international accounts were up 24% quarter-over-quarter, showing our sustained focus on broadening revenue sources; and revenue from our materials and Trans Logistics site in Raceland, Louisiana, working with the world's leading oilfield services providers, jumped by over 53% quarter-over-quarter, as that location became central to delivering services that limited Hurricane Ida's effects; and we keep making meaningful headway in restoring our indirect routes to market alongside service companies; we've cemented a partnership with ProFrac to supply downhole chemistries to its hydraulic fracturing fleets across North America. If shareholders approve the contract extension, we expect combined organic and suitable related 2023 revenues to far surpass $200 million. Beyond that, the segment has kept expanding into nearby energy markets, generating revenue in geothermal drilling and cementing work, along with solar panel coatings. Aiming to reduce risk, we're still in talks with major suppliers to lock in future purchase pricing and material allocation volumes for our leading product lines in 2022, as our attention stays on faster growth and wider margins. Lastly, we're happy to report that Flotek finished the year with 0 total recordables and 0 hours of nonproductive time across field and manufacturing operations, which further demonstrates our dedication to performing for customers and fulfilling our value proposition. Looking ahead, we're enthusiastic about what's next and the ongoing possibilities for our Chemistry Technologies segment, as we keep enabling our customers to operate using our improved chemistry solutions. I'll now hand the call to Mike so he can go over our financial results.

Mike Borton

executive
#5

Thanks, Ryan. Like John said before, the 10-K now shows gross margin in the consolidated statement of operations for the first time since 2017. Segment level sales and marketing costs plus corporate G&A are now merged and reported as selling, general and administration on the statement of operations. Cost of goods sold, as now reported, stands for product costs, transportation and certain other costs needed to produce and deliver goods and services. The company made these reporting changes trying to give greater transparency and after a significant review of industry peers and in consultation with our external auditors. Now let's walk through the income statement in more depth. In Q4, consolidated revenue came to $12.2 million, a 20% rise from the $10.2 million in Q3 and a slight increase over the $12.1 million of revenue in the same period a year ago. Total revenue for the year fell 19% from 2020, mainly hit by the M&A activity affecting 2 significant customers and the nonrecurring sales of excess terpene. Even with lower revenue for the year, our losses shrank versus last year, both in Q4 and for the full year, as we run our business more efficiently throughout the organization. By segment, Chemistry Technology, including the effect of excess terpene sales, posted a 23% sequential revenue gain, or $11.6 million for Q4. That also marks a 7% rise from the same period in 2020. The Data Analytics segment had a 27% sequential sales decline from Q3, caused by several product purchases being delayed into 2022. In Q4, we took an $8.1 million impairment of goodwill, about $0.11 loss per diluted share tied to the Data Analytics segment. In the end, we think this asset holds considerable value over the long term. The impairment decision is a noncash transaction that will reflect a slower ramp-up of cash flows as we keep moving certain customers to a Data-as-a-Service model. We closed the year with consolidated gross margin of $3.3 million, a substantial improvement from a loss of $28.7 million in 2020. The main reason for these differences in gross margin dollars between the periods came from the accrual of the ADM reserve in Q4 2020 of $9.4 million and the later reversal of this reserve in Q3 '21, which was the settlement payment of $1.75 million. Q4 SG&A was $5.8 million, up $1.7 million from Q3 2021; this increase comes from the elimination of the Federal Employee Retention Credit Program, Data Analytics severance and the fact that the 2021 management incentive plan accruals were reversed in Q3; we keep renegotiating annual contracts to drive even more improvement in our expense run rate; for the year, we reported a loss of $30.5 million, or $0.42 loss per diluted share for 2021, a sharp improvement over the loss of $136.5 million, or $2 loss per diluted share last year. Within the 2020 figure for loss per diluted share, there were several notable one-time items: $1.28 tied to impairment, $0.26 related to ADM terpene reserves, and $0.14 from product rationalization. For Q4, adjusted EBITDA came in at a loss of $5.7 million, and that compares favorably both with the $6.3 million loss recorded in Q3 and the $6.8 million loss posted in last year's fourth quarter. Late in 2021, we also managed to lease out 2 facilities that had been sitting idle, and doing so lifted our EBITDA run rate by about $250,000 each quarter. Now let's turn to how the balance sheet performed, since keeping our liquidity intact remains a priority. When Q4 ended, cash equivalents stood at $11.6 million, down from $20.5 million at the close of Q3. A number of things affected where our cash stood: losses from operations, working capital pressure on receivables and inventory brought on by higher revenue, and outlays connected to the ADM settlement. Under the Paycheck Protection Program tied to the CARES Act, the company carries $4.8 million in outstanding loans. Forgiveness was sought on substantially the entire loan late in Q3 2021. As for the expected forgiveness amounts, we have yet to get final word from the SBA, though we anticipate that soon. Looking ahead to 2022, we aim to keep capitalizing on back office cost efficiencies, expand our top line through both organic and ProFrac related revenue, and secure the working capital required to carry out our growth strategies; back in February 2022, as previously announced, Flotek completed a $21.2 million pipe. Flotek remains engaged with Piper Sandler on a range of other cash generation efforts, among them, though not limited to, GAAP and ongoing monetization of noncore assets, in order to fund the ProFrac working capital needs discussed earlier. We expect both our Marlow and Monahans facilities to be sold within the next several months, with proceeds to the company exceeding $6 million. Lastly, before handing the call back to John, I want to take a moment to thank the accounting and internal audit teams, along with a number of other Flotek employees, whose efforts supported the successful remediation of our 2020 material weaknesses. That was difficult work, and it stands as one more illustration of building a robust governance and monitoring program, one that will help this company keep delivering on our commitments. With that, I'll return the call to John for his closing remarks.

John Gibson

executive
#6

Mike, thank you. As it stands now, Flotek is a lean-running company set up to grow profitably over the long haul, with a crew capable of carrying out our goal of providing solutions that lower the environmental footprint of energy on air, water, land and people. My view is that there's ample reason for optimism in the coming year; we've watched several major players, especially among energy producers, report sizable gains already during 2021. There's usually a delay between what happens with producers and what service companies feel, but we think a good deal of the momentum operators currently enjoy will translate into benefits for us too. Turning to 2022, we expect — we think we can keep the budget level, and our margins are going to get better. As I mentioned before, we held an investor call not long ago to lay out more clearly the components and consequences of our ProFrac contract, which delivers $225-plus million in contracted revenue across the coming 3 years, a huge upside over the next decade. Along with organic growth, we expect our first month of business profitability in 2022, and from then on profitability should continue without interruption. When I came aboard the Flotek team in January 2020, I brought a forward-looking mindset. Today we're confident that the ProFrac deal could lock in our future and let us keep looking ahead. Naturally, this depends on approval at our upcoming special shareholder meeting, so I want to use this last chance to urge you strongly to cast your vote in favor of the proposals in our proxy right now. To wrap up, I simply want to thank everyone here at Flotek; this has been a test of endurance, and we've come out of it in a strong, successful position to move ahead, with particular thanks to our customers and our shareholders for sticking with us. You're all great; and with that, operator, I'll hand it back to you for questions.

Jeff Robertson

analyst
#7

Ryan, could you discuss a bit the capacity utilization for the Energy Chemistry business during 2022 and 2023, considering the ProFrac contract, and also the penetration among other service company customers regarding use of the capacity they aren't currently taking up?

Ryan Ezell

executive
#8

Yes, absolutely. That's a great question. Looking at some of the unique aspects, first, regarding the ProFrac contract, it is a nonexclusive agreement. This lets us keep growing in our other market areas. Regarding capacity in our existing manufacturing operations, we were actually operating at probably under what I'd consider 15% total utilization to support our field services and chemical blending operations, and that was only during a typical day shift. Considering the growth from — just the ProFrac piece, combined with the potential parts of where we're headed, we'll still likely be at near full operations with ProFrac. We'll probably remain under 52% of our operational capacity for what we can manage without any CapEx spending. So we certainly have room to expand without spending much money on support. And believe it or not, historically, going back to years like 2017, we actually handled 300 million pounds of chemicals that year, which aligns with — similar to how we'll be expanding in the ProFrac operations, our organic growth. So we still have considerable space to use before we reach any point of needing capital expansion. The unique aspect of how we're handling the service delivery model now is that we also incorporate support, and we don't have to route all the chemicals through our primary manufacturing facilities, since some are essentially repackaged materials we purchase when we consider the lower-end technologies; so we source those within the basin and deliver them directly to the rig site, from rail spurs and so on, from some of the chemical companies we partner with for that. Thus we have a strong opportunity not only to pursue the nonexclusivity elements of the ProFrac contract to grow the core business, but also to have capacity for this growth over the long term before any major capital expansion is required.

Jeff Robertson

analyst
#9

Ryan, just so I understand correctly — that 52% capacity figure, is that the amount that's going to serve the ProFrac contract, covering the supply, the amendment, and also what Flotek's baseline business looked like during 2021?

Ryan Ezell

executive
#10

Yes, that's right. Exactly right.

Jeff Robertson

analyst
#11

All right. Regarding ProFrac specifically — in the areas where they run operations, and where crews of theirs will be stationed that you'll be providing service to, could that assist in boosting — possibly boosting Flotek's margins with additional clients in that region by handing you greater scale?

Ryan Ezell

executive
#12

Without a doubt. Without a doubt. That's something we truly sense. As more — clearly, as we push greater volume through, it aids us on the leverage side in specific regions where we can pursue improved margins. There's also — the single major benefit that vendors genuinely appreciate is this: when we're able to provide them a precise projection of that volume, and we begin examining businesses such as ProFrac and even a few of the other firms we've added through our organic operations, we gain far superior lead time for projecting which kinds of materials we'll be consuming, and that hands us stronger negotiating power with our vendors, helping us bring down our total expenses and apply that toward better margins, and that's right.

Jeff Robertson

analyst
#13

All right. Mike, you brought up collaborating with Piper regarding alternatives. Could you discuss the — given that pipe financing closed in February alongside the initial supply agreement, what portion of the working capital needed for the supply agreement under the expand — or rather the supply amendment is accounted for by the funds you all secured through that transaction?

Mike Borton

executive
#14

Thanks for asking, Jeff. In the near term, we believe the pipe covers most of it. Obviously, our projections extend outward and indicate we'll require additional amounts down the road; we're working to figure out exactly how much; that hinges on the pace at which they ramp up and likewise on how we monetize the organization's other assets.

Jeff Robertson

analyst
#15

So just to make sure I've got this right — the problem you're describing is something further out, rather than something happening right now?

Mike Borton

executive
#16

That's right. That's right.

Nick Bigney

executive
#17

Operator, prior to taking the following question from the queue, one submission arrived via e-mail intended for John, sent by Eric Swergold of Firestorm Capital. The inquiry Eric raised was this: regarding ProFrac's contracted position, how sensitive is it to oil prices?

John Gibson

executive
#18

I'll give a short response, and then Ryan can take it from there. What's really encouraging about this agreement—and I hope people pick up on this—is that it provides stability no matter where oil prices go. Under the deal, we're guaranteed 70% of the crews, with a floor of 30 crews. Since they're currently at 45 crews, that number would need to drop by almost 33% before we'd hit 30 crews or fewer. I don't see any commodity pricing situation that would lead to crew cuts of that magnitude. So essentially—I believe we're among the few service providers with genuine backlog locked in that extends a decade out, and it holds up under today's pricing conditions. That makes me quite enthusiastic, knowing we can plan ahead and have a strong revenue base behind us. Ryan, anything you'd like to add?

Ryan Ezell

executive
#19

Yes, I believe that's accurate, John, and it matches what I've been thinking too. When you consider the short term, especially regarding a contract that runs about 10 years, what stands out is the considerable insulation provided by how ProFrac runs its business. And I'd add that what we refer to as certain top-tier service providers are beginning to secure extended durations for the work they perform, rather than operating on such a well-by-well transactional basis. This likewise gives us substantial assurance about the scope of work and how we project our materials. So that's the reason, I'd say, the major shift we're beginning to observe concerning capital discipline, especially within these top-tier hydraulic fracturing activities, is that they now possess a longer guaranteed form of work scope, and that, I hope, brings us steadiness in the short term when oil prices are considered as well.

John Gibson

executive
#20

One more item that gets me energized: we’ll be speaking with you once more, likely in 6 or 7 weeks, when we release Q1 results. By then, April will be behind us, and that will be the first month when we’re truly accelerating on this contract. We’re thrilled about how we’ve already started working with them and about how many crews are being added, and we can’t wait to share specifics during that Q1 call, where we’ll be able to lay out how strongly the ramp-up is going. That should give you a very clear picture of what 2022 will look like, so we’re quite excited. Let’s return and take one more call. Nick?

Michael Heim

analyst
#21

I want to understand the character of the sales tied to Data Analytics a bit better. I heard Mike say that certain projects may have slipped into 2022, and I fully realize this can be an uneven business. Yet at the same time, we were writing down, recording the goodwill impairment. I'm just curious whether you could elaborate a little more on what these sales look like, the timing questions, and how particular projects or customers have played a role in shifting when things land?

Mike Borton

executive
#22

Sure. James is sitting here with me as well. When we examined it, the impairment matter truly came down to sensitivity and discount rates. We looked at it, and I don't want to be doing this every quarter; so we simply — we used what third parties gave us, we believed it was realistic, and we just went ahead and wrapped it up, since at this point we're so focused on the chemistry business and how large it will become. I don't want major and minor items here next quarter. So it's like, let's concentrate on where we're genuinely going to earn money. Meanwhile, we have an enormous amount of upside with some sizable opportunities in Data Analytics, and sales cycles get a bit longer. But we're enthusiastic about the use cases, enthusiastic about new customers. And with that, I'll let James give you a few more highlights, but a great business.

James Silas

executive
#23

Thanks for that, Mike. I simply wanted to drive home a few of the points I raised previously during this call. Our aim truly is to move away from one-off usage or a lone project and toward broader technology uptake on the customer's end. Achieving that requires discussions with customers across several tiers, plus forming alliances with additional service providers so that we can deliver a packaged offering to them too; these are items we're eager to discuss further once we bring them into action later this year.

Jeff Robertson

analyst
#24

James, following up on Data Analytics — I believe you brought up a pilot program internationally and a shift toward more of an enterprise-style offering for customers. Could you speak to the sorts of obstacles that have to be dealt with, and what those efforts would translate into when it comes to selling units throughout that entire company's platform rather than as individual deals?

James Silas

executive
#25

Absolutely. Glad to talk about it. As for those pilot programs abroad, things are proceeding on the timeline we set, since you're working with national oil companies. Timelines have a way of sliding between 18 months and 24 months from the first proposal until you wrap up those programs, and right now we're midway through that stretch. Our thinking is that if we can bring those to a successful conclusion — and our expectation is that we will — additional markets will open up for us, larger than what we've got available at present in North America; so it's exciting to get those going and demonstrate value, and we'll be glad to share more once there's something we can say.

Jeff Robertson

analyst
#26

And does the objective partly involve securing adoption of the JP3 systems at a corporate level rather than, say, by 1 manager and 1 plant? So that corporate buys in and rolls it out over a far wider asset base?

John Gibson

executive
#27

Yes. What James was attempting to get across, I believe, is that our aim leans more toward being a platform rather than a device. And in chasing that, we've in fact been collaborating with a few outfits — dashboard or process engineering companies, as I'd describe them — on the question of how we insert our sensor into their processes. My guess is you'll see us going after that over the coming quarter or thereabouts, since that's what backs the way it has to function inside a national oil company. A device isn't really what they're after. What they're after is a platform that backs business decision. So we're lifting it up from a device sale to a business decision support device. It isn't merely a sensor, and that's the direction James is headed. And I'm pretty enthusiastic about it, and we look forward to discussing that further down the road. With that, I believe we've probably run out of time for questions this morning, and I simply want to thank everyone for being with us. Please go back and review the call from March 10 that covered the ProFrac contract. Please get on — get in there and vote in favor of this proxy. We're thrilled about working with them; and I think you're going to start to see the impacts, especially in Q3 and Q4, but you'll see the ramp-up and how thrilling this is going to be for us going out for the next decade; and you're going to have a company that truly has an annuity in terms of revenue that we can count on and that we're going to build our cost structure around so we could provide positive results. So thanks, guys. I really appreciate it. Take care.

Operator

operator
#28

That brings us to the end of this call. We appreciate your joining the presentation today. You're welcome to log off at this point.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.